This finding aligns with previous reports linking elevated serum PTX3 levels to type 2 diabetes in obese patients with nonalcoholic fatty liver disease, indicating the clinical relevance of PTX3 in metabolic disorders (Karamfilova et al., 2022, Trojak et al., 2019). The gene discussed is PTX3; the disease is metabolic disease.